The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
A subset of platinum-containing chemotherapeutic agents kills cells by inducing ribosome biogenesis stress
Open accessAbstract
Cisplatin and its platinum analogs, carboplatin and oxaliplatin, are some of the most widely used cancer chemotherapeutics. Although cisplatin and carboplatin are used primarily in germ cell, breast and lung malignancies, oxaliplatin is instead used almost exclusively to treat colorectal and other gastrointestinal cancers. Here we utilize a unique, multi-platform genetic approach to study the mechanism of action of these clinically established platinum anti-cancer agents, as well as more recently developed cisplatin analogs. We show that oxaliplatin, unlike cisplatin and carboplatin, does not kill cells through the DNA-damage response. Rather, oxaliplatin kills cells by inducing ribosome biogenesis stress. This difference in drug mechanism explains the distinct clinical implementation of oxaliplatin relative to cisplatin, and it might enable mechanistically informed selection of distinct platinum drugs for distinct malignancies. These data highlight the functional diversity of core components of front-line cancer therapy and the potential benefits of applying a mechanism-based rationale to the use of our current arsenal of anti-cancer drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn923 · Cited by 14,108
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,925
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830
Goldberg, R. M., Sargent, D. J., Morton, R. F., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Pitot, H. C., & Alberts, S. R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.046 · Cited by 2,249
The comet assay: a method to measure DNA damage in individual cells
Olive, P. L., & Banáth, J. P. (2006) · Nature Protocols · doi:10.1038/nprot.2006.5 · Cited by 1,835
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789
Willett, P., Barnard, J. M., & Downs, G. M. (1998) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci9800211 · Cited by 1,765
Bonner, W. M., Redon, C. E., Dickey, J. S., Nakamura, A. J., Sedelnikova, O. A., Solier, S., & Pommier, Y. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2523 · Cited by 1,623
Self-citationThe CHEK2-Breast Cancer Consortium (2002) · Nature Genetics · doi:10.1038/ng879 · Cited by 1,104
Boulon, S., Westman, B. J., Hutten, S., Boisvert, F.-M., & Lamond, A. I. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.024 · Cited by 1,103
Reinhold, W. C., Sunshine, M., Liu, H., Varma, S., Kohn, K. W., Morris, J., Doroshow, J., & Pommier, Y. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1370 · Cited by 887
Self-citationRogakou, E. P., Nieves-Neira, W., Boon, C., Pommier, Y., & Bonner, W. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9390 · Cited by 708
Self-citationOxaliplatin: A review of preclinical and clinical studies
Raymond, E., Chaney, S. G., Taamma, A., & Cvitkovic, E. (1998) · Annals of Oncology · doi:10.1023/a:1008213732429 · Cited by 643
Rixe, O., Ortuzar, W., Alvarez, M., Parker, R., Reed, E., Paull, K., & Fojo, T. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)81490-6 · Cited by 615
Probing tumor phenotypes using stable and regulated synthetic microRNA precursors
Dickins, R. A., Hemann, M. T., Zilfou, J. T., Simpson, D. R., Ibarra, I., Hannon, G. J., & Lowe, S. W. (2005) · Nature Genetics · doi:10.1038/ng1651 · Cited by 524
Self-citationChemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels
Burger, K., Mühl, B., Harasim, T., Rohrmoser, M., Malamoussi, A., Orban, M., Kellner, M., Gruber-Eber, A., Kremmer, E., Hölzel, M., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.074211 · Cited by 458
Imaging protein synthesis in cells and tissues with an alkyne analog of puromycin
Liu, J., Xu, Y., Stoleru, D., & Salic, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111561108 · Cited by 447
Machover, D., Diaz-Rubio, E., de Gramont, A., Schilf, A., Gastiaburu, J.-J., Brienza, S., Itzhaki, M., Metzger, G., N'Daw, D., Vignoud, J., et al. (1996) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a010489 · Cited by 434
Repair of Cisplatin−DNA Adducts by the Mammalian Excision Nuclease
Zamble, D. B., Mu, D., Reardon, J. T., Sancar, A., & Lippard, S. J. (1996) · Biochemistry · doi:10.1021/bi960453+ · Cited by 333
Self-citationPark, G. Y., Wilson, J. J., Song, Y., & Lippard, S. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207670109 · Cited by 330
Self-citationBertucci, F., Salas, S., Eysteries, S., Nasser, V., Finetti, P., Ginestier, C., Charafe-Jauffret, E., Loriod, B., Bachelart, L., Montfort, J., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207262 · Cited by 326
Oxaliplatin-Induced Damage of Cellular DNA
Woynarowski, J. M., Faivre, S., Herzig, M. C. S., Arnett, B., Chapman, W. G., Trevino, A. V., Raymond, E., Chaney, S. G., Vaisman, A., Varchenko, M., et al. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12463-7 · Cited by 310
The combined status of ATM and p53 link tumor development with therapeutic response
Jiang, H., Reinhardt, H. C., Bartkova, J., Tommiska, J., Blomqvist, C., Nevanlinna, H., Bartek, J., Yaffe, M. B., & Hemann, M. T. (2009) · Genes & Development · doi:10.1101/gad.1815309 · Cited by 304
Self-citationmTORC1-mediated translational elongation limits intestinal tumour initiation and growth
Faller, W. J., Jackson, T. J., Knight, J. R. P., Ridgway, R. A., Jamieson, T., Karim, S. A., Jones, C., Radulescu, S., Huels, D. J., Myant, K. B., et al. (2015) · Nature · doi:10.1038/nature13896 · Cited by 302
Zuber, J., McJunkin, K., Fellmann, C., Dow, L. E., Taylor, M. J., Hannon, G. J., & Lowe, S. W. (2011) · Nature Biotechnology · doi:10.1038/nbt.1720 · Cited by 267
p53 and ribosome biogenesis stress: The essentials
Golomb, L., Volarevic, S., & Oren, M. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.014 · Cited by 242
Alvarez, M., Paull, K., Monks, A., Hose, C., Lee, J. S., Weinstein, J., Grever, M., Bates, S., & Fojo, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117910 · Cited by 216
Stage II Colon Cancer Prognosis Prediction by Tumor Gene Expression Profiling
Barrier, A., Boelle, P.-Y., Roser, F., Gregg, J., Tse, C., Brault, D., Lacaine, F., Houry, S., Huguier, M., Franc, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.0229 · Cited by 214
Voss, M. H., Hakimi, A. A., Pham, C. G., Brannon, A. R., Chen, Y.-B., Cunha, L. F., Akin, O., Liu, H., Takeda, S., Scott, S. N., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2345 · Cited by 214
Williams, R. T., Roussel, M. F., & Sherr, C. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602030103 · Cited by 193
Defining principles of combination drug mechanisms of action
Pritchard, J. R., Bruno, P. M., Gilbert, L. A., Capron, K. L., Lauffenburger, D. A., & Hemann, M. T. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210419110 · Cited by 168
Self-citationAwuah, S. G., Zheng, Y.-R., Bruno, P. M., Hemann, M. T., & Lippard, S. J. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b10182 · Cited by 164
Self-citationTHE CALCULATION OF MICROBIAL ASSAYS
Bliss, C. I. (1956) · Bacteriological Reviews · doi:10.1128/br.20.4.243-258.1956 · Cited by 163
Breast Cancer Stem Cell Potent Copper(II)–Non‐Steroidal Anti‐Inflammatory Drug Complexes
Boodram, J. N., Mcgregor, I. J., Bruno, P. M., Cressey, P., Hemann, M. T., & Suntharalingam, K. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510443 · Cited by 149
Self-citationMaede, Y., Shimizu, H., Fukushima, T., Kogame, T., Nakamura, T., Miki, T., Takeda, S., Pommier, Y. G., & Murai, J. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0551 · Cited by 142
Self-citationScagliotti, G. V., Kortsik, C., Dark, G. G., Price, A., Manegold, C., Rosell, R., O'Brien, M. E. R., Peterson, P. M., Castellano, D., Selvaggi, G., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.690.11.2 · Cited by 139
Gene-Expression Profiling Predicts Recurrence in Dukes’ C Colorectal Cancer
Arango, D., Laiho, P., Kokko, A., Alhopuro, P., Sammalkorpi, H., Salovaara, R., Nicorici, D., Hautaniemi, S., Alazzouzi, H., Mecklin, J., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.066 · Cited by 137
The chicken B cell line DT40: a novel tool for gene disruption experiments
Winding, P., & Berchtold, M. W. (2001) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00333-1 · Cited by 134
Fritzmann, J., Morkel, M., Besser, D., Budczies, J., Kosel, F., Brembeck, F. H., Stein, U., Fichtner, I., Schlag, P. M., & Birchmeier, W. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.03.041 · Cited by 129
A mammalian functional-genetic approach to characterizing cancer therapeutics
Jiang, H., Pritchard, J. R., Williams, R. T., Lauffenburger, D. A., & Hemann, M. T. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.503 · Cited by 104
Self-citationSuntharalingam, K., Johnstone, T. C., Bruno, P. M., Wei, L., Hemann, M. T., & Lippard, S. J. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4075375 · Cited by 102
Self-citationA Breast Cancer Stem Cell-Selective, Mammospheres-Potent Osmium(VI) Nitrido Complex
Suntharalingam, K., Wei, L., Johnstone, T. C., Bruno, P. M., Zheng, Y., Hemann, M. T., & Lippard, S. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja508808v · Cited by 101
Self-citationNecroptosis-Inducing Rhenium(V) Oxo Complexes
Suntharalingam, K., Awuah, S. G., Bruno, P. M., Johnstone, T. C., Wang, F., Wei, L., Zheng, Y., Page, J. E., Hemann, M. T., & Lippard, S. J. (2015) · Journal of the American Chemical Society · doi:10.1021/ja511978y · Cited by 98
Self-citationAddressing Genetic Tumor Heterogeneity through Computationally Predictive Combination Therapy
Zhao, B., Pritchard, J. R., Lauffenburger, D. A., & Hemann, M. T. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0465 · Cited by 98
Self-citationActivity of oxaliplatin against human tumor colony-forming units.
Raymond, É., Lawrence, R., Izbicka, E., Faivre, S. J., & Hoff, D. D. V. (1998) · PubMed · Cited by 79
The gene expression profile represents the molecular nature of liver metastasis in colorectal cancer
Yamasaki, M., Takemasa, I., Komori, T., Watanabe, S., Sekimoto, M., Doki, Y., Matsubara, K., & Monden, M. (2007) · International Journal of Oncology · doi:10.3892/ijo.30.1.129 · Cited by 71
Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic review
Shelley, M. D., Burgon, K., & Mason, M. D. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00059-2 · Cited by 68
Scagliotti, G. V. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-9009 · Cited by 62
Fojo, T., Farrell, N., Ortuzar, W. I., Tanimura, H., Weinstein, J. N., & Myers, T. G. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.008 · Cited by 53
Barnes, J. C., Bruno, P. M., Nguyen, H. V. ‐., Liao, L., Liu, J., Hemann, M. T., & Johnson, J. A. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b06321 · Cited by 50
Self-citationcDNA microarray-based identification of genes and pathways associated with oxaliplatin resistance
Samimi, G., Manorek, G., Castel, R., Breaux, J. K., Cheng, T. C., Berry, C. C., Los, G., & Howell, S. B. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0819-9 · Cited by 45
Kim, M. K., Osada, T., Barry, W. T., Yang, X. Y., Freedman, J. A., Tsamis, K. A., Datto, M., Clary, B. M., Clay, T. D., Morse, M. A., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0937 · Cited by 41
The Potent Inhibitory Effect of a Naproxen‐Appended Cobalt(III)‐Cyclam Complex on Cancer Stem Cells
Cressey, P., Eskandari, A., Bruno, P. M., Lü, C., Hemann, M. T., & Suntharalingam, K. (2016) · ChemBioChem · doi:10.1002/cbic.201600368 · Cited by 41
Self-citationAtmaca, A., Al-Batran, S.-E., Werner, D., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.555 · Cited by 34
Predicting cancer drug mechanisms of action using molecular network signatures
Pritchard, J. R., Bruno, P. M., Hemann, M. T., & Lauffenburger, D. A. (2012) · Molecular BioSystems · doi:10.1039/c2mb25459j · Cited by 28
Self-citationMechanistic studies of the anticancer activity of an octahedral hexanuclear Pt(II) cage
Zheng, Y., Suntharalingam, K., Bruno, P. M., et al. (2016) · Inorganica Chimica Acta · doi:10.1016/j.ica.2016.03.021 · Cited by 24
Self-citationRaez, L. E., Santos, E. S., Junior, G. L. L., Rosado, M. F., Negret, L. M., Rocha‐Lima, C., Tolba, K., Farfán, N., Hamilton‐Nelson, K. L., Silva, O., et al. (2006) · Lung Cancer · doi:10.1016/j.lungcan.2006.05.023 · Cited by 20
Cited by
Cisplatin: The first metal based anticancer drug
Ghosh, S. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.102925 · Cited by 1,751
Ribosome biogenesis in cancer: new players and therapeutic avenues
Pelletier, J., Thomas, G., & Volarević, S. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.104 · Cited by 812
Lamarca, A., Palmer, D. H., Wasan, H. S., Ross, P. J., Ma, Y. T., Arora, A., Falk, S., Gillmore, R., Wadsley, J., Patel, K., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00027-9 · Cited by 769
Metallodrugs are unique: opportunities and challenges of discovery and development
Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 692
Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636
Metadata
- Authors
- Bruno, P. M., Liu, Y., Park, G. Y., Murai, J., Koch, C. E., Eisen, T. J., Pritchard, J. R., Pommier, Y., Lippard, S. J., & Hemann, M. T.
- Venue
- Nature Medicine
- Published
- 2017-02-27
- Volume
- 23
- Issue
- 4
- Pages
- 461-471
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2591905283
- Cited by
- 519
- References
- 67
- FWCI
- 20.14
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.